Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| MX Orthopedics Receives FDA Clearance on the dynaMX(TM) Compression Staple | ||
| By: PR Newswire Association LLC. - 10 Feb 2016 | Back to overview list |
|
LEXINGTON, Mass., Feb. 10, 2016 /PRNewswire/ -- MX Orthopedics Corp. (MXO) is a privately held company focused on improving implant/bone fixation. MXO is proud to announce the recent FDA clearance (K153129) of the dynaMX™ Compression Staple (patent pending). MXO's dynaMX™ line of fracture fixation implants include: superelastic compression staples, screws, plates, and intramedullary implants. MXO applies sound engineering principles and sophisticated metallurgical know-how to the design of superelastic implants in order to optimize biologic healing. Deleterious implant instability and bone resorption can be minimized through calculated implant internal fixation forces generated between bone segments. The dynaMX™ line is engineered to generate and sustain higher levels of compression at the fracture site as the bone remodels. MXO's sophisticated products are Engineered to Heal™. Benefits of the dynaMX™ Compression Staple include:
Please find information about the dynaMX™ Compression Staple at: http://www.mxortho.com/products/compression-staples/ Please also visit MXO at:
Contact: MX Orthopedics, Corp.
SOURCE MX Orthopedics, Corp. 
|
||
|
|
||
 | Back to overview list | |